Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hepatorenal syndrome].

I Kürer1, A Sommerer, G Puhl

  • 1Klinik für Anästhesiologie und operative Intensivmedizin, Charité, Campus Virchow-Klinikum, Universitätsmedizin Berlin.

Der Anaesthesist
|December 24, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Unusual esophageal tumor].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2018
Same author

[Interhospital transport of patients with ARDS].

Der Anaesthesist·2017
Same author

Efficacy and Effects of Parenteral Pethidine or Meptazinol and Regional Analgesia for Pain Relief during Delivery. A Comparative Observational Study.

Geburtshilfe und Frauenheilkunde·2016
Same author

[S3 guidelines on volume therapy: Comments on publication 2014].

Der Anaesthesist·2015
Same author

Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT).

RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin·2014
Same author

Technical feasibility of liver transplantation without cold storage.

Langenbeck's archives of surgery·2013
Same journal

[Promoting young academics in anesthesiology: factors for an attractive internship].

Der Anaesthesist·2022
Same journal

[Respiratory support in COVID-19: all in due time!]

Der Anaesthesist·2022
Same journal

[Noninvasive respiratory support and invasive ventilation in COVID‑19 : Where do we stand today?]

Der Anaesthesist·2022
Same journal

[Management of acutely decompensated liver cirrhosis in emergency and critical care medicine].

Der Anaesthesist·2022
Same journal

[Anesthesia in patients with acute porphyria].

Der Anaesthesist·2022
Same journal

[Quality and safe anesthesia for all children : That is their right!]

Der Anaesthesist·2022
See all related articles

Hepatorenal syndrome (HRS) is a serious kidney complication in advanced liver disease. It affects 8% of patients with ascites and significantly impacts prognosis, though its exact causes remain unclear.

Area of Science:

  • Nephrology
  • Hepatology
  • Internal Medicine

Context:

  • Hepatorenal syndrome (HRS) is a critical complication in patients with advanced chronic liver disease and portal hypertension.
  • Renal insufficiency in HRS develops when other causes of kidney failure are ruled out.
  • The incidence of HRS in patients with refractory ascites is 8%, highlighting its prevalence in this population.

Purpose:

  • To define hepatorenal syndrome (HRS) and its diagnostic criteria.
  • To outline the incidence and prognostic significance of HRS in end-stage liver disease.
  • To underscore the complexity and incomplete understanding of HRS pathogenesis.

Summary:

  • Hepatorenal syndrome (HRS) is characterized by renal insufficiency in the context of chronic liver disease and portal hypertension.

Related Experiment Videos

  • It is diagnosed by excluding other causes of functional renal failure.
  • The overall incidence of renal failure in end-stage liver disease is 75%, with HRS being a significant component.

    • Impact:

    • HRS serves as a predictive marker for the prognosis of end-stage liver failure.
    • Understanding HRS is crucial for managing patients with advanced liver disease and preventing kidney complications.
    • Further research into the complex pathogenesis of HRS is needed to improve patient outcomes.